29 agosto 2014
Raloxifene is a US Food and Drug Administration-approved treatment for decreasing fracture risk in osteoporosis. While raloxifene is as effective at reducing fracture risk as other current treatments, this works only partially by suppressing bone loss. X-ray studies revealed an additional mechanism underlying raloxifene action, providing an explanation for how this drug can achieve equivalent clinical benefit.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/YmmL6mZk-Hg/140829135457.htm
